Kohlberg Kravis Roberts & Co’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-113,562	Closed	-$1.14M	–	116
2022 Q4	$1.14M	Hold	113,562	–	–	0.04%	67
2022 Q3	$1.12M	Hold	113,562	–	–	0.02%	107
2022 Q2	$1.11M	Hold	113,562	–	–	0.01%	129
2022 Q1	$1.11M	Buy	113,562 +5,144	+5%	+$50K	0.01%	140
2021 Q4	$1.05M	Sell	108,418 -4,699	-4%	-$45.7K	0.01%	105
2021 Q3	$1.1M	Buy	+113,117	New	+$1.09M	0.01%	100

Kohlberg Kravis Roberts & Co's MSAC Position: Q1 2023 in Review

Kohlberg Kravis Roberts & Co sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 113,562 shares — an estimated $1.14M sold.

Kohlberg Kravis Roberts & Co first reported a position in MSAC in Q3 2021 and held it in 6 quarters. The position peaked at $1.14M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Kohlberg Kravis Roberts & Co reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Kohlberg Kravis Roberts & Co sold 113,562 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $1.14M.
Kohlberg Kravis Roberts & Co first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q3 2021 and held it in 6 quarters.
Kohlberg Kravis Roberts & Co's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $1.14M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q1 2023, filed 15 May 2023.